Aliskiren versus lercanidipine in patients with hypertension uncontrolled with two classes of antihypertensives
Phase of Trial: Phase II
Latest Information Update: 29 Apr 2012
At a glance
- Drugs Aliskiren (Primary) ; Lercanidipine (Primary) ; Antihypertensives
- Indications Hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms ASPIV
- 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
- 11 Jul 2011 New trial record
- 20 Jun 2011 Results presented at the 21st European Meeting on Hypertension.